Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation. FitzGerald GA, Smith B, Pedersen AK, Brash AR (1984) N Engl J Med 310: 1065-8 Rational use of analgesic and antiinflammatory drugs. Crofford LJ (2001) N Engl J Med 345: 1844-6 Effect of dipyridamole plus aspirin on hemodialysis graft patency. Dixon BS, Beck GJ, Vazquez MA, Greenberg A, Delmez JA, Allon M, Dember LM, Himmelfarb J, Gassman JJ, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Fenves AZ, Kaufman JS, Cotton JR, Martin KJ, McNeil JW, Rahman A, Lawson JH, Whiting JF, Hu B, Meyers CM, Kusek JW, Feldman HI, DAC Study Group (2009) N Engl J Med 360: 2191-201 Systemic prostaglandin I2 synthesis is normal in patients with Bartter's syndrome. Watson ML, Gill JR, Branch RA, Oates JA, Brash AR (1983) Lancet 2: 368-70 Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study. Ray WA, Stein CM, Hall K, Daugherty JR, Griffin MR (2002) Lancet 359: 118-23 Platelet aggregates in peripheral and coronary-sinus blood in patients with spontaneous coronary-artery spasm. Robertson RM, Robertson D, Friesinger GC, Timmons S, Hawiger J (1980) Lancet 2: 829-31 Adenosine diphosphate induces binding of von Willebrand factor to human platelets. Fujimoto T, Hawiger J (1982) Nature 297: 154-6 Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets. Hawiger J, Parkinson S, Timmons S (1980) Nature 283: 195-7 Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Santoro SA (1986) Cell 46: 913-20 Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Ellis EF, Oelz O, Roberts LJ, Payne NA, Sweetman BJ, Nies AS, Oates JA (1976) Science 193: 1135-7 Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, Himmelfarb J, Vazquez MA, Gassman JJ, Greene T, Radeva MK, Braden GL, Ikizler TA, Rocco MV, Davidson IJ, Kaufman JS, Meyers CM, Kusek JW, Feldman HI, Dialysis Access Consortium Study Group (2008) JAMA 299: 2164-71 Relative importance of thrombin compared with plasmin-mediated platelet activation in response to plasminogen activation with streptokinase. Winters KJ, Santoro SA, Miletich JP, Eisenberg PR (1991) Circulation 84: 1552-60 Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries. Hennan JK, Huang J, Barrett TD, Driscoll EM, Willens DE, Park AM, Crofford LJ, Lucchesi BR (2001) Circulation 104: 820-5 Clopidogrel and the concept of high-risk pharmacokinetics. Roden DM, Stein CM (2009) Circulation 119: 2127-30 Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop. Newman JH, Fanburg BL, Archer SL, Badesch DB, Barst RJ, Garcia JG, Kao PN, Knowles JA, Loyd JE, McGoon MD, Morse JH, Nichols WC, Rabinovitch M, Rodman DM, Stevens T, Tuder RM, Voelkel NF, Gail DB, National Heart, Lung and Blood Institute/Office of Rare Diseases (2004) Circulation 109: 2947-52 Responding to the clopidogrel warning by the US food and drug administration: real life is complicated. Roden DM, Shuldiner AR (2010) Circulation 122: 445-8 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2014) J Am Coll Cardiol 64: e1-76 Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study. Ray WA, Murray KT, Griffin MR, Chung CP, Smalley WE, Hall K, Daugherty JR, Kaltenbach LA, Stein CM (2010) Ann Intern Med 152: 337-45 Defective thrombus formation in mice lacking coagulation factor XII. Renné T, Pozgajová M, Grüner S, Schuh K, Pauer HU, Burfeind P, Gailani D, Nieswandt B (2005) J Exp Med 202: 271-81 Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. Carneiro AM, Cook EH, Murphy DL, Blakely RD (2008) J Clin Invest 118: 1544-52 Modulation of human platelet protein kinase C by endotoxic lipid A. Grabarek J, Timmons S, Hawiger J (1988) J Clin Invest 82: 964-71 Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. Weiss HJ, Hawiger J, Ruggeri ZM, Turitto VT, Thiagarajan P, Hoffmann T (1989) J Clin Invest 83: 288-97 Collagen-mediated platelet aggregation. Evidence for multivalent interactions of intermediate specificity between collagen and platelets. Santoro SA, Cunningham LW (1977) J Clin Invest 60: 1054-60 Staphylococci-induced human platelet injury mediated by protein A and immunoglobulin G Fc fragment receptor. Hawiger J, Steckley S, Hammond D, Cheng C, Timmons S, Glick AD, Des Prez RM (1979) J Clin Invest 64: 931-7 Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. FitzGerald GA, Oates JA, Hawiger J, Maas RL, Roberts LJ, Lawson JA, Brash AR (1983) J Clin Invest 71: 676-88 Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man. FitzGerald GA, Brash AR, Oates JA, Pedersen AK (1983) J Clin Invest 72: 1336-43 The effects of RO-22-4679, a thromboxane synthetase inhibitor, on ventricular fibrillation induced by coronary artery occlusion in conscious dogs. Huddleston CB, Lupinetti FM, Laws KH, Collins JC, Clanton JA, Hawiger JJ, Oates JA, Hammon JW (1983) Circ Res 52: 608-13 Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Moore KP, Darley-Usmar V, Morrow J, Roberts LJ (1995) Circ Res 77: 335-41 CIB1 is an endogenous inhibitor of agonist-induced integrin alphaIIbbeta3 activation. Yuan W, Leisner TM, McFadden AW, Wang Z, Larson MK, Clark S, Boudignon-Proudhon C, Lam SC, Parise LV (2006) J Cell Biol 172: 169-75 Mapping of epitopes for monoclonal antibodies against human platelet thrombospondin with electron microscopy and high sensitivity amino acid sequencing. Galvin NJ, Dixit VM, O'Rourke KM, Santoro SA, Grant GA, Frazier WA (1985) J Cell Biol 101: 1434-41 Biological role of prolyl 3-hydroxylation in type IV collagen. Pokidysheva E, Boudko S, Vranka J, Zientek K, Maddox K, Moser M, Fässler R, Ware J, Bächinger HP (2014) Proc Natl Acad Sci U S A 111: 161-6 A monoclonal antibody against human thrombospondin inhibits platelet aggregation. Dixit VM, Haverstick DM, O'Rourke KM, Hennessy SW, Grant GA, Santoro SA, Frazier WA (1985) Proc Natl Acad Sci U S A 82: 3472-6 gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors. Hawiger J, Timmons S, Kloczewiak M, Strong DD, Doolittle RF (1982) Proc Natl Acad Sci U S A 79: 2068-71 Fibronectin and the multiple interaction model for platelet-collagen adhesion. Santoro SA, Cunningham LW (1979) Proc Natl Acad Sci U S A 76: 2644-8 Inhibition of platelet aggregation by a monoclonal antibody against human fibronectin. Dixit VM, Haverstick DM, O'Rourke K, Hennessy SW, Broekelmann TJ, McDonald JA, Grant GA, Santoro SA, Frazier WA (1985) Proc Natl Acad Sci U S A 82: 3844-8 GPVI and alpha2beta1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow. Sarratt KL, Chen H, Zutter MM, Santoro SA, Hammer DA, Kahn ML (2005) Blood 106: 1268-77 Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface. Braaten JV, Jerome WG, Hantgan RR (1994) Blood 83: 982-93 Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Laidlaw TM, Kidder MS, Bhattacharyya N, Xing W, Shen S, Milne GL, Castells MC, Chhay H, Boyce JA (2012) Blood 119: 3790-8
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.